A Study of [18F]LY4214835 in Healthy Volunteers and Participants With Cancer

Summary

The purpose of the study is to check how safe and well-tolerated \[18F\]LY4214835 injection is in healthy participants and participants with cancer. The study drug will be administered intravenously (IV) (into a vein). Participation in the study will last approximately 35 days.

Timeline

Start

2025-12-22

Primary completion

2027-01

Completion

2027-01

Drugs

Indications